FDA moves toward easing restrictions on certain peptides BioPharma Dive Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 Journal of Pharmaceutical Innovation Springer Nature Link FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. Americans are injecting themselves with unproven peptides 6abc Philadelphia The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular